Seamount Financial Group
PFE icon

Seamount Financial Group’s Pfizer PFE Stock Holding History

Seamount Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$205K Buy
+7,184
New +$191K 0.08% 141
2026
Q2 		– Sell
-7,634
Closed -$214K – 144
2026
Q1 		$214K Buy
+7,634
New +$203K 0.1% 129
2025
Q3 		– Sell
-9,341
Closed -$226K – 138
2025
Q2 		$226K Buy
+9,341
New +$218K 0.12% 120

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Seamount Financial Group's PFE Position: Q3 2026 in Review

Seamount Financial Group opened a new position in Pfizer (PFE) in Q3 2026: 7,184 shares worth $205K. The stake represents 0.08% of the portfolio and ranks #141 among its holdings. This is a return to the name: Seamount Financial Group previously reported a position in PFE as recently as Q1 2026.

Seamount Financial Group first reported a position in PFE in Q2 2025 and has held it in 3 quarters since. The position peaked at $226K in Q2 2025. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Seamount Financial Group held 7,184 shares of Pfizer worth $205K as of Q3 2026.
  • Pfizer was a new Seamount Financial Group position in Q3 2026.
  • Pfizer made up 0.08% of Seamount Financial Group's portfolio in Q3 2026, its #141 holding.
  • Seamount Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 3 quarters since.
  • Seamount Financial Group's Pfizer position peaked at $226K in Q2 2025.
  • 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Seamount Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.